Outlook Therapeutics Inc banner

Outlook Therapeutics Inc
NASDAQ:OTLK

Watchlist Manager
Outlook Therapeutics Inc Logo
Outlook Therapeutics Inc
NASDAQ:OTLK
Watchlist
Price: 0.219 USD 4.29% Market Closed
Market Cap: $18.2m

Wall Street
Price Targets

OTLK Price Targets Summary
Outlook Therapeutics Inc

There are no price targets for OTLK.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Outlook Therapeutics Inc Competitors:
Price Targets
CENT
Central Garden & Pet Co
37% Upside
QNST
Quinstreet Inc
68% Upside

Revenue
Forecast

-12% / Year
Past Growth
154% / Year
Estimated Growth
Estimates Accuracy
N/A
Average
-12% / Year
Past Growth
154% / Year
Estimated Growth
Estimates Accuracy
N/A
Average

For the last 10 years the compound annual growth rate for Outlook Therapeutics Inc's revenue is -12%. The projected CAGR for the next 3 years is 154%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OTLK's stock price target?
Not Available

OTLK doesn't have any price targets made by Wall Street professionals.

What is Outlook Therapeutics Inc's Revenue forecast?
Projected CAGR
154%

For the last 10 years the compound annual growth rate for Outlook Therapeutics Inc's revenue is -12%. The projected CAGR for the next 3 years is 154%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett